Holen Sie sich die Stockscreener-App
29.34
3.31%
0.94
Finanzdaten der Akero Therapeutics Inc-Aktie (AKRO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Research and Development |
5.14%
50.65
|
53.39 | 38.63 | 27.98 | 21.79 |
| Interest Income/Expense |
10.48%
0.991
|
0.897 | 0.888 | 0.857 | 0.457 |
| Operating Income/Loss |
3.10%
-59.95
|
-61.87 | -46.62 | -35.63 | -28.75 |
| Income/Loss From Continuing Operations Before Tax |
3.34%
-53.34
|
-55.19 | -39.66 | -31.08 | -25.83 |
| Income/Loss From Continuing Operations After Tax |
3.34%
-53.34
|
-55.19 | -39.66 | -31.08 | -25.83 |
Net Income/Loss
|
3.34%
-53.34
|
-55.19 | -39.66 | -31.08 | -25.83 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
5,488%
59.31
|
1.0614 | 55.61 | 51.87 | 46.94 |
| Diluted Average Shares |
5,488%
59.31
|
1.0614 | 55.61 | 51.87 | 46.94 |
| Basic Earnings Per Share |
11.76%
-0.90
|
-1.02 | -0.71 | -0.60 | -0.55 |
| Diluted Earnings Per Share |
11.76%
-0.90
|
-1.02 | -0.71 | -0.60 | -0.55 |
| Common Stock Dividends |
-
|
- | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):